Kerendia
My Prescription
Payment
Select pharmacy
$702.42
Print or send this coupon to your phone
AlbertsonsPowered byAbout Kerendia
Drug Details
Finerenone, marketed as Kerendia, is a medication designed for individuals with type 2 diabetes and chronic kidney disease (CKD) to help safeguard their kidney and heart health. It is specifically approved to slow down kidney damage progression, decrease the risk of kidney failure, and mitigate the chances of heart-related issues such as heart attacks and heart failure hospitalization. Finerenone functions as a mineralocorticoid receptor antagonist, effectively blocking the influence of aldosterone and cortisol, which can lead to inflammation and scarring in the kidneys, heart, and blood vessels when unchecked. By reducing salt retention and preventing overactivity of these receptors, finerenone supports better kidney and cardiovascular health. This medication is taken orally once a day, with the dose tailored according to kidney function and individual response. Some common side effects include elevated potassium levels, lowered blood pressure, and reduced sodium levels. Always consult healthcare professionals before starting any new medication regimen.
Price history for Kerendia
30 Tablets, 10MG
Average retail price for Kerendia
Average SaveHealth price for Kerendia
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Kerendia dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10MG | 30 Tablets | $702.62 | $23.42 |
| 10MG | 1 Tablet | $29.07 | $29.07 |
| 10MG | 7 Tablets | $173.46 | $24.78 |
| 10MG | 90 Tablets | $2,073.86 | $23.04 |
| 20MG | 1 Tablet | $29.07 | $29.07 |
| 20MG | 7 Tablets | $173.46 | $24.78 |
| 20MG | 30 Tablets | $702.21 | $23.41 |
Kerendia FAQs
Kerendia (finerenone) is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. It works by blocking mineralocorticoid receptors, which play a role in inflammation and fibrosis in the kidneys and heart.
Kerendia and Farxiga are not the same medication. They are different drugs used for different purposes. Kerendia (finerenone) is used to reduce the risk of kidney and heart complications in patients with chronic kidney disease associated with type 2 diabetes. Farxiga (dapagliflozin) is primarily used to improve blood sugar control in adults with type 2 diabetes and is also used to reduce the risk of hospitalization for heart failure in certain patients.
Kerendia (finerenone) is not known to reverse kidney damage. It is used to slow the progression of chronic kidney disease in patients with type 2 diabetes. It helps reduce the risk of kidney function decline and cardiovascular events, but it does not reverse existing kidney damage.
Kerendia (finerenone) may cause several side effects and potential issues. Common side effects include hyperkalemia (elevated potassium levels), hypotension (low blood pressure), and hyponatremia (low sodium levels). Patients with severe kidney impairment or those taking certain medications may be at increased risk for these side effects. It is important for patients to have their kidney function and electrolyte levels monitored regularly while taking Kerendia. Additionally, patients should discuss their full medical history and current medications with their healthcare provider to avoid potential drug interactions.
Yes, Kerendia (finerenone) and Farxiga (dapagliflozin) can be taken together, but it is important to do so under the guidance of a healthcare provider. Both medications are used to manage conditions related to heart and kidney health, and their combined use should be monitored to ensure safety and effectiveness. The healthcare provider will consider the patient's overall health, kidney function, and any potential interactions or side effects.